TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ELV

Elevance Health Inc

Healthcare · Healthcare Plans

398.60$ -1.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios ELV
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
Valuation
16.8 18.5 19.4 18.9 18.9 14.3 16.7 16.4 13.2 13.7 12.3 17.0
0.6 0.6 0.7 0.7 0.7 0.5 0.5 0.5 0.4 0.4 0.3 0.4
2.7 2.8 3.0 3.0 2.8 2.1 2.3 2.0 1.7 1.8 1.5 1.9
0.7 0.8 0.8 0.9 0.8 0.6 0.7 0.6 0.5 0.5 0.4 0.5
11.0 12.4 13.2 13.2 13.0 10.3 11.6 11.1 9.6 10.4 9.7 13.1
12.5 16.4 52.9 154.2 139.2 18.7 26.9 16.5 19.4 24.5 10.0 13.4
8.0% 6.1% 1.9% 0.6% 0.7% 5.3% 3.7% 6.1% 5.2% 4.1% 10.0% 7.5%
Margins
58.7% 43.4% 27.7% 28.3% 27.9% 27.9% 27.7% 26.8% 26.3% 25.6% 23.2% 39.0%
4.4% 5.0% 5.3% 5.5% 5.3% 5.0% 4.8% 4.5% 4.4% 4.1% 3.8% 3.5%
3.7% 3.5% 3.6% 3.9% 3.7% 3.4% 3.2% 2.8% 2.8% 2.8% 2.6% 2.5%
4.9% 3.9% 1.3% 0.5% 0.5% 2.6% 2.0% 2.8% 1.9% 1.6% 3.2% 3.1%
Returns
15.9% 15.3% 15.4% 15.9% 14.7% 14.5% 13.9% 12.3% 12.6% 12.9% 11.9% 11.1%
5.5% 5.5% 5.6% 5.9% 5.5% 5.1% 4.9% 4.4% 4.5% 4.7% 4.2% 3.9%
Balance Sheet & Debt
14,097 18,758 20,225 21,189 19,282 23,097 22,503 21,626 23,389 22,686 21,835 20,812
1.3 1.8 1.9 1.9 1.8 2.2 2.2 2.2 2.3 2.3 2.4 2.6
34.8% 36.1% 36.3% 37.3% 37.6% 35.3% 35.5% 35.9% 35.8% 36.1% 34.9% 35.5%
0.7 0.6 0.7 0.7 0.6 0.8 0.7 0.7 0.7 0.7 0.7 0.7
Per Share
25.89 25.45 26.66 28.67 27.53 25.88 26.04 23.74 24.50 25.53 23.79 22.78
709.04 726.63 733.33 735.73 746.53 765.08 806.00 838.15 862.80 897.77 909.32 922.96
162.47 166.69 173.39 180.77 187.79 178.78 187.07 193.63 194.65 197.84 199.19 205.98
34.87 28.69 9.80 3.51 3.74 19.70 16.17 23.64 16.68 14.31 29.26 28.86

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?